Literature DB >> 20179431

State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop.

Raymond L Barnhill1, Lorenzo Cerroni, Martin Cook, David E Elder, Helmut Kerl, Philip E LeBoit, Stanley W McCarthy, Martin C Mihm, Wolter J Mooi, Michael W Piepkorn, Victor G Prieto, Richard A Scolyer.   

Abstract

The following communication summarizes the proceedings of a one-day International Workshop focusing on the histology of benign melanocytic nevi. Areas of controversy identified in 6 focus sessions were the nomenclature and relationships among common nevi including nevi with halo reactions, traumatized nevi, "dysplastic" nevi, and nevi from particular anatomic sites; developmental biology and frequency of malignant transformation associated with congenital nevi; the characterization and biologic nature of atypical spitzoid neoplasms; the basic definition of particular melanocytic cellular phenotypes, and the nomenclature and biologic nature of many candidate blue nevi, combined nevi, and other controversial lesions such as deep penetrating nevus and pigmented epithelioid melanocytoma. Concentrated data collection and follow-up, molecular characterization, and future consensus Workshops may facilitate the resolution of some of these problems. The Group recommended the description of ambiguous or "borderline" lesions as tumors with indeterminate or uncertain biologic/malignant potential. The participants also advised that such lesions at a minimum should be managed by complete excision with clear surgical margins.

Entities:  

Mesh:

Year:  2010        PMID: 20179431     DOI: 10.1097/PAP.0b013e3181cfe758

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  12 in total

1.  SF3B1 and BAP1 mutations in blue nevus-like melanoma.

Authors:  Klaus G Griewank; Hansgeorg Müller; Louise A Jackett; Michael Emberger; Inga Möller; Johannes Ap van de Nes; Lisa Zimmer; Elisabeth Livingstone; Thomas Wiesner; Simone L Scholz; Ioana Cosgarea; Antje Sucker; Tobias Schimming; Uwe Hillen; Bastian Schilling; Annette Paschen; Henning Reis; Thomas Mentzel; Heinz Kutzner; Arno Rütten; Rajmohan Murali; Richard A Scolyer; Dirk Schadendorf
Journal:  Mod Pathol       Date:  2017-04-14       Impact factor: 7.842

2.  Oral atypical cellular blue nevus: an infiltrative melanocytic proliferation.

Authors:  Brian S Shumway; Yeshwant B Rawal; Carl M Allen; John R Kalmar; Cynthia M Magro
Journal:  Head Neck Pathol       Date:  2012-08-01

Review 3.  [Dysplastic melanocytic nevus].

Authors:  E Bierhoff
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

4.  Variation among pathologists' treatment suggestions for melanocytic lesions: A survey of pathologists.

Authors:  Kachiu C Lee; Sue Peacock; Martin A Weinstock; Ge Alice Zhao; Stevan R Knezevich; David E Elder; Raymond L Barnhill; Michael W Piepkorn; Lisa M Reisch; Patricia A Carney; Tracy Onega; Jason P Lott; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2016-09-28       Impact factor: 11.527

5.  Junctional spitz tumor (nevus) of the upper lip.

Authors:  Evangelia P Piperi; Konstantinos I Tosios; Alexandra Sklavounou; Eric Stich; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2013-11-29

6.  Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.

Authors:  Berta M Geller; Paul D Frederick; Stevan R Knezevich; Jason P Lott; Heidi D Nelson; Linda J Titus; Patricia A Carney; Anna N A Tosteson; Tracy L Onega; Raymond L Barnhill; Martin A Weinstock; David E Elder; Michael W Piepkorn; Joann G Elmore
Journal:  Dermatol Surg       Date:  2018-02       Impact factor: 3.398

7.  Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.

Authors:  Inga Möller; Rajmohan Murali; Hansgeorg Müller; Thomas Wiesner; Louise A Jackett; Simone L Scholz; Ioana Cosgarea; Johannes Ap van de Nes; Antje Sucker; Uwe Hillen; Bastian Schilling; Annette Paschen; Heinz Kutzner; Arno Rütten; Martin Böckers; Richard A Scolyer; Dirk Schadendorf; Klaus G Griewank
Journal:  Mod Pathol       Date:  2016-12-09       Impact factor: 7.842

Review 8.  Intracranial melanocytic meningeal tumours and melanosis oculi: case report and literature review.

Authors:  Francesco Doglietto; Cesare Colosimo; Libero Lauriola; Mario Balducci; Pasquale De Bonis; Nicola Montano; Gelareh Zadeh; Giulio Maira; Roberto Pallini
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

9.  Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival.

Authors:  Guangdi Chen; Yabin Cheng; Zhizhong Zhang; Magdalena Martinka; Gang Li
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

10.  miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions.

Authors:  V Grignol; E T Fairchild; J M Zimmerer; G B Lesinski; M J Walker; C M Magro; J E Kacher; V I Karpa; J Clark; G Nuovo; A Lehman; S Volinia; D M Agnese; C M Croce; W E Carson
Journal:  Br J Cancer       Date:  2011-08-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.